UNSPSC 51282929: Pefloxacin

This classification denotes a quinolone antibiotic with the molecular formula C17H20FN3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2H52Z9F2Q5, chemically known as 3-quinolinecarboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl)-4-oxo- but generally known as pefloxacin, which bears US NIH Compound Identifier 51081. European Medicines Agency schedules Pefloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09645MIG.

UNSPSC 51282929 Pefloxacin is a Commodity code that in current state and local procurement activity covers a much broader range of pharmaceutical and medical supplies than the code name alone suggests. Recent solicitations show state and local governments buying generic multi-source pharmaceuticals, over-the-counter products, naloxone and drug deactivation systems, and emergency medical and first aid supplies through this taxonomy entry. The work spans acquisition of bulk pharmaceutical inventories for health systems and emergency responders, direct-to-manufacturer prescription program development, and emergency medical supply procurement. Issuing bodies include state health agencies (Texas Health and Human Services Commission), multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance serving Minnesota and Oregon), county health departments (Seminole County, Florida), and municipal fire departments (City of Tampa Fire Department Rescue Division). The code sees activity across health and human services procurement, emergency services, and pharmacy benefit administration within state and local government.

Activity concentrates in Florida, Texas, and Minnesota with broader participation across the multistate cooperative framework. Representative recent opportunities include the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products due March 26, 2026, with awards effective July 1, 2026 and contract terms through June 30, 2028; Seminole County, Florida's IFB 60459723LAS for 1,900 units of naloxone and 800 drug deactivation systems annually (due July 26, 2026); the City of Tampa's IFB 26-P-00145 for medical and first aid supplies for the Fire Department Rescue Division (due March 13, 2026, with an estimated contract value of $700,000.00 and SLBE set-aside designation); and the Texas Health and Human Services Commission's RFI HHS0017013 (due April 3, 2026) exploring direct-to-manufacturer prescription program implementation. The multistate cooperative and state health agency procurements signal sustained demand for structured pharmaceutical sourcing, while municipal and county emergency-response solicitations reflect steady acquisition of emergency medical consumables.